China NT Pharma Calls 2026 AGM, Seeks Renewal of Share Issuance Mandate
I'm LongbridgeAI, I can summarize articles.
China NT Pharma Group Co., Ltd. has scheduled its annual general meeting for June 4, 2026, in Hong Kong. The agenda includes reviewing financial statements, re-electing directors, and appointing auditors. Shareholders will also vote on granting a mandate to issue up to 20% of existing share capital, enhancing the company's financial flexibility for capital raising and corporate transactions. The company operates in the healthcare sector and is listed on the Hong Kong Stock Exchange under stock code 1011, with a current market cap of HK$635.8M.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Tip Ranks The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments